Figure 5
IC 50 values for the targeted drugs bortezomib, sorafenib, sunitinib and rapamycin in all tumor samples investigated divided for the subtypes indicated. Results are presented as mean values + SE. Number of samples investigated for each drug and type of sample is indicated on the x-axis labeling. Statistical interference was calculated with one-way ANOVA with Dunnet’s post-test and with the colorectal cancer samples as reference. *P < 0.05; NS, not statistically significant.